Verrica Pharmaceuticals Inc. Annual Share-based Payment Arrangement, Expense in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Verrica Pharmaceuticals Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2017 to 2023.
  • Verrica Pharmaceuticals Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $2.11M, a 78.2% decline year-over-year.
  • Verrica Pharmaceuticals Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $8.48M, a 37% decline year-over-year.
  • Verrica Pharmaceuticals Inc. annual Share-based Payment Arrangement, Expense for 2023 was $14.4M, a 188% increase from 2022.
  • Verrica Pharmaceuticals Inc. annual Share-based Payment Arrangement, Expense for 2022 was $4.99M, a 17.6% decline from 2021.
  • Verrica Pharmaceuticals Inc. annual Share-based Payment Arrangement, Expense for 2021 was $6.05M, a 38.4% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $14.4M +$9.39M +188% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 $4.99M -$1.07M -17.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 $6.05M -$3.77M -38.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-06
2020 $9.82M +$6.49M +195% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-02
2019 $3.33M +$1.08M +48.1% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-17
2018 $2.25M +$2.17M +2645% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-13
2017 $82K Jan 1, 2017 Dec 31, 2017 10-K 2019-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.